These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31443351)

  • 1. Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells.
    Schmidtova S; Kalavska K; Gercakova K; Cierna Z; Miklikova S; Smolkova B; Buocikova V; Miskovska V; Durinikova E; Burikova M; Chovanec M; Matuskova M; Mego M; Kucerova L
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31443351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness.
    Schmidtova S; Dorssers LCJ; Kalavska K; Gillis AJM; Oosterhuis JW; Stoop H; Miklikova S; Kozovska Z; Burikova M; Gercakova K; Durinikova E; Chovanec M; Mego M; Kucerova L; Looijenga LHJ
    Cancer Cell Int; 2020; 20():364. PubMed ID: 32774158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines.
    Schmidtova S; Kalavska K; Liskova V; Plava J; Miklikova S; Kucerova L; Matuskova M; Rojikova L; Cierna Z; Rogozea A; Konig H; Albany C; Mego M; Chovanec M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the PARP inhibitor veliparib on germ cell tumor cell lines.
    Schmidtova S; Udvorkova N; Cierna Z; Horak S; Kalavska K; Chovanec M; Rojikova L; Vulevova M; Kucerova L; Mego M
    Oncol Lett; 2022 Nov; 24(5):392. PubMed ID: 36276487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micro-RNA expression in cisplatin resistant germ cell tumor cell lines.
    Port M; Glaesener S; Ruf C; Riecke A; Bokemeyer C; Meineke V; Honecker F; Abend M
    Mol Cancer; 2011 May; 10():52. PubMed ID: 21575166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors.
    Schmidtova S; Kalavska K; Kucerova L
    Curr Oncol Rep; 2018 Sep; 20(11):88. PubMed ID: 30259297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
    Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
    J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
    Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
    Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and roles of system L amino acid transporters in human embryonal carcinoma cells.
    Chatsirisupachai K; Kitdumrongthum S; Panvongsa W; Janpipatkul K; Worakitchanon W; Lertjintanakit S; Wongtrakoongate P; Chairoungdua A
    Andrology; 2020 Nov; 8(6):1844-1858. PubMed ID: 32741077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors.
    Lengert AVH; Pereira LDNB; Cabral ERM; Gomes INF; Jesus LM; Gonçalves MFS; Rocha AOD; Tassinari TA; Silva LSD; Laus AC; Vidal DO; Pinto MT; Reis RM; Lopes LF
    Front Biosci (Landmark Ed); 2022 Aug; 27(8):245. PubMed ID: 36042160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition.
    Cavallo F; Graziani G; Antinozzi C; Feldman DR; Houldsworth J; Bosl GJ; Chaganti RS; Moynahan ME; Jasin M; Barchi M
    PLoS One; 2012; 7(12):e51563. PubMed ID: 23251575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
    Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
    Zhu H; Yun F; Shi X; Wang D
    Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells.
    Durinikova E; Kozovska Z; Poturnajova M; Plava J; Cierna Z; Babelova A; Bohovic R; Schmidtova S; Tomas M; Kucerova L; Matuskova M
    BMC Cancer; 2018 Aug; 18(1):848. PubMed ID: 30143021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours.
    Roška J; Lobo J; Ivovič D; Wachsmannová L; Mueller T; Henrique R; Jerónimo C; Chovanec M; Jurkovičová D
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
    Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ
    Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel sequential therapy with metformin enhances the effects of cisplatin in testicular germ cell tumours via YAP1 signalling.
    He K; Li Z; Ye K; Zhou Y; Yan M; Qi H; Hu H; Dai Y; Tang Y
    Cancer Cell Int; 2022 Mar; 22(1):113. PubMed ID: 35264157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
    Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
    Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial.
    Mego M; Svetlovska D; Angelis V D; Kalavska K; Lesko P; Makovník M; Obertova J; Orszaghova Z; Palacka P; Rečková M; Rejlekova K; Z SM; Mardiak J; Chovanec M
    Invest New Drugs; 2022 Oct; 40(5):1080-1086. PubMed ID: 35763178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
    Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.